These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 7817437)

  • 1. [Failure of fluoroquinolone treatment in pneumococcal pneumonia].
    Skov RL; Hertz JB
    Ugeskr Laeger; 1994 Nov; 156(48):7232-4. PubMed ID: 7817437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Penicillins for treatment of pneumococcal pneumonia: does in vitro resistance really matter?
    Peterson LR
    Clin Infect Dis; 2006 Jan; 42(2):224-33. PubMed ID: 16355333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia.
    Ross JJ; Worthington MG; Gorbach SL
    N Engl J Med; 2002 Jul; 347(1):65-7; author reply 65-7. PubMed ID: 12097545
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.
    Hayashi K; Kadowaki SE; Takei M; Fukuda H
    Antimicrob Agents Chemother; 2006 Feb; 50(2):748-51. PubMed ID: 16436736
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Parenteral treatment of severe bronchopulmonary infections using trimethoprim and sulfamethoxazole].
    Iglauer E; Wieser O
    Wien Med Wochenschr; 1973 May; 123(20):322-3. PubMed ID: 4705885
    [No Abstract]   [Full Text] [Related]  

  • 6. Fluoroquinolones: how to use (but not overuse) these antibiotics.
    Sable CA; Scheld WM
    Geriatrics; 1993 Jun; 48(6):41-4, 49-51. PubMed ID: 8500773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
    Jónsdóttir K; Kristinsson KG
    Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical relevance of antimicrobial resistance in the management of pneumococcal community-acquired pneumonia.
    Feldman C
    J Lab Clin Med; 2004 May; 143(5):269-83. PubMed ID: 15122171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of Streptococcus pneumoniae infection treatment failures associated with fluoroquinolone resistance.
    Fuller JD; Low DE
    Clin Infect Dis; 2005 Jul; 41(1):118-21. PubMed ID: 15937772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blood culture and susceptibility results and allergy history do not influence fluoroquinolone use in the treatment of community-acquired pneumonia.
    Chang NN; Murray CK; Houck PM; Bratzler DW; Greenway C; Guglielmo BJ
    Pharmacotherapy; 2005 Jan; 25(1):59-66. PubMed ID: 15767221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Levofloxacine for the treatment of pneumococcal pneumonia: results of a meta-analysis].
    Bru JP; Leophonte P; Veyssier P
    Rev Pneumol Clin; 2003 Dec; 59(6):348-56. PubMed ID: 14745340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reply to: Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
    Rubinstein E
    J Antimicrob Chemother; 2003 May; 51(5):1307-8; author reply 1308-9. PubMed ID: 12697636
    [No Abstract]   [Full Text] [Related]  

  • 13. A new fluoroquinolone for community-acquired pneumonia.
    Young LS
    Clin Infect Dis; 1998 Jun; 26(6):1322-3. PubMed ID: 9636856
    [No Abstract]   [Full Text] [Related]  

  • 14. Trovafloxacin-induced acute hepatitis.
    Lucena MI; Andrade RJ; Rodrigo L; Salmerón J; Alvarez A; Lopez-Garrido MJ; Camargo R; Alcantára R
    Clin Infect Dis; 2000 Feb; 30(2):400-1. PubMed ID: 10671353
    [No Abstract]   [Full Text] [Related]  

  • 15. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of bacteremic and non-bacteremic pneumococcal pneumonia.
    Jover F; Cuadrado JM; Andreu L; Martínez S; Cañizares R; de la Tabla VO; Martin C; Roig P; Merino J
    Eur J Intern Med; 2008 Jan; 19(1):15-21. PubMed ID: 18206596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of the new quinolone WCK 771 against pneumococci.
    Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF
    Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New fluoroquinolones in lower respiratory tract infections and emerging patterns of pneumococcal resistance.
    Ferrara AM
    Infection; 2005 Jun; 33(3):106-14. PubMed ID: 15940410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New quinolones].
    Kakeya H; Fukushima K; Saito A
    Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():542-8. PubMed ID: 17455678
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ethonium in the prevention and treatment of acute pneumonia].
    Lidvanskaia LS; Koren' VS
    Ter Arkh; 1978; 50(3):49-51. PubMed ID: 653595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.